Traditional Chinese medicine for the Dyslipidemia caused by highly active antiretroviral therapies (HARRT): a randomized control trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001253

Enrollment

Unknown

Registered

2011-03-16

Start date

2009-05-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS, dyslipidemia

Interventions

Treatment:Basic treatment+TCM

Control:Basic treatment

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. HIV antibody test: Postive; 2. Patients who are receiving HARRT. Lipid profile is normal before HARRT or once normal during the HARRT. Dyslipidemia occured after the HARRT started; 3. aged 18 to 65 years old; 4. Patients without severe liver, heart, or lung disease; 5. Patients voluntarily signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with psychological disease including severe hysteria; 2. Patients who are alergic or intolerant to the trial drug; 3. Pregnant or lactating women, or women who have birth plan; 4. Patients with any other disease or history that could confound the results or increase risk; 5. Patients received other treatment for dyslipidemia in last month; 6. Patients participated in other clinical trial.

Design outcomes

Primary

Measure	Time frame
Lipid profile;	—

Countries

China

Contacts

Public ContactYu Mao

myqmz58@yahoo.com+86 13552484984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026